Back
RiverNorth Managed Duration Municipal Income Fund II Vs. Neurogene Industry Stock Comparison
Sell
35
RMMZ
RiverNorth Managed Duration Municipal Income Fund II
Last Price:
15.74
Seasonality Move:
15.15%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Sell
35
RiverNorth Managed Duration Municipal Income Fund II (RMMZ)
is a Sell
Is RiverNorth Managed Duration Municipal Income Fund II a Buy, Sell or Hold?
- The current RiverNorth Managed Duration Municipal Income Fund II [RMMZ] share price is $15.70. The Score for RMMZ is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RMMZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RMMZ Stock Price Chart
What is RiverNorth Managed Duration Municipal Income Fund II's stock price today?
-
The RiverNorth Managed Duration Municipal Income Fund II share price today is $15.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RMMZ is experiencing selling pressure, which indicates risk of future bearish movement.
RMMZ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 38.17 | Sell |
Chaikin Money Flow: | -37061 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.76 - 16.28) | Sell |
Bollinger Bands (100): | (15.87 - 16.27) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 35.74 | Sell |
Chaikin Money Flow: | -452975 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.4 - 61.5) | Sell |
Bollinger Bands (100): | (34.32 - 50.52) | Sell |
RMMZ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.84 | Sell |
20-day SMA: | 15.93 | Sell |
50-day SMA: | 16.12 | Sell |
200-day SMA: | 15.99 | Sell |
8-day EMA: | 15.85 | Sell |
20-day EMA: | 15.94 | Sell |
50-day EMA: | 16.04 | Sell |
200-day EMA: | 15.92 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.3 | Sell |
20-day SMA: | 51.47 | Sell |
50-day SMA: | 46.76 | Sell |
200-day SMA: | 38.99 | Sell |
8-day EMA: | 47.13 | Sell |
20-day EMA: | 50.2 | Sell |
50-day EMA: | 47.47 | Sell |
200-day EMA: | 38.44 | Sell |
RiverNorth Managed Duration Municipal Income Fund II Earnings Growth & RMMZ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
RiverNorth Managed Duration Municipal Income Fund II Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |